1. Home
  2. PT vs CODX Comparison

PT vs CODX Comparison

Compare PT & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pintec Technology Holdings Limited

PT

Pintec Technology Holdings Limited

HOLD

Current Price

$1.01

Market Cap

14.7M

Sector

Technology

ML Signal

HOLD

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$5.90

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PT
CODX
Founded
2012
2013
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
15.6M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
PT
CODX
Price
$1.01
$5.90
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$67.50
AVG Volume (30 Days)
68.2K
77.4K
Earning Date
09-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
$507,892.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
9.20
N/A
52 Week Low
$0.76
$4.84
52 Week High
$1.38
$46.50

Technical Indicators

Market Signals
Indicator
PT
CODX
Relative Strength Index (RSI) 58.23 96.13
Support Level $0.92 $0.17
Resistance Level $0.99 $0.30
Average True Range (ATR) 0.05 0.22
MACD 0.01 0.69
Stochastic Oscillator 80.00 97.84

Price Performance

Historical Comparison
PT
CODX

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: